Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-kappaB activation in dendritic cells.

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the presence of autoantibodies and lupus nephritis. The [New Zealand black (NZB) x New Zealand white (NZW)]F1 (BWF1) mouse has been recognized as an important animal model of human SLE. The T(h)1-prone phenotype of BWF1 mice has been shown to contribute to the development of the lupus. However, the molecular basis for T(h)1 skewing in BWF1 mice has not been clarified. We noticed that IL-6, IL-12 and other proinflammatory cytokines as well as IkappaB-zeta induction were higher in mature bone marrow-derived dendritic cells (BMDCs) from NZB and BWF1 mice than those from NZW mice. The expression of an IFN-inducible gene Ifi202, a candidate gene for lupus, was almost undetectable in NZW BMDCs. Thus, we hypothesized that Ifi202 is involved in elevated IL-12 production from BWF1 BMDCs. Overexpression of Ifi202 enhanced the LPS-induced IkappaB-zeta, IL-12p40 and NF-kappaB promoter activities, while anti-sense (AS) RNA against Ifi202 strongly suppressed them in a monocytic cell line, RAW 264.7. Furthermore, overexpression of Ifi202 enhanced LPS-induced IL-12p40 and IkappaB-zeta mRNA induction while Ifi202 AS RNA suppressed these in RAW 264.7 cells. In addition, forced expression of Ifi202 enhanced IL-12p40 mRNA induction in NZW BMDCs. Thus, Ifi202 is an important NF-kappaB activator in DCs and involved in IL-12 production, which may account for a T(h)1-prone phenotype of BWF1 mice.

[1]  Taku Sato,et al.  Aberrant High Expression of B Lymphocyte Chemokine (Blc/Cxcl13) by C11b+Cd11c+ Dendritic Cells in Murine Lupus and Preferential Chemotaxis of B1 Cells towards Blc , 2001, The Journal of experimental medicine.

[2]  D. Wofsy,et al.  Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. , 1994, The Journal of clinical investigation.

[3]  K. Murphy,et al.  Regulation of interleukin 12 p40 expression through an NF-kappa B half-site , 1995, Molecular and cellular biology.

[4]  S. Akira,et al.  Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. , 2004, Nature.

[5]  D. Choubey,et al.  Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice , 2003, The Journal of experimental medicine.

[6]  鈴木 明日香.  Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein , 2004 .

[7]  A. Yoshimura,et al.  Modulation of TLR signalling by the C‐terminal Src kinase (Csk) in macrophages , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[8]  K. Okumura,et al.  Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. , 1997, Journal of immunology.

[9]  Werner Müller,et al.  Interleukin-4 Protects against a Genetically Linked Lupus-like Autoimmune Syndrome , 1997, The Journal of experimental medicine.

[10]  T. Muta,et al.  Stimulus-specific Induction of a Novel Nuclear Factor-κB Regulator, IκB-ζ, via Toll/Interleukin-1 Receptor Is Mediated by mRNA Stabilization* , 2004, Journal of Biological Chemistry.

[11]  M. Howard,et al.  Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice , 1994, The Journal of experimental medicine.

[12]  K. Hunt,et al.  P202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells. , 2003, Biochemical and biophysical research communications.

[13]  G. Feng,et al.  Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP , 1999, Journal of immunology.

[14]  M. Kubo,et al.  Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. , 2003, Immunity.

[15]  B. Kotzin.  Systemic Lupus Erythematosus , 1996, Cell.

[16]  J. Banchereau,et al.  IFN-α Induces Early Lethal Lupus in Preautoimmune (New Zealand Black × New Zealand White)F1 but Not in BALB/c Mice1 , 2005, The Journal of Immunology.

[17]  B. Ryffel,et al.  IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice. , 1998, Journal of immunology.

[18]  P. Lengyel,et al.  The Interferon-inducible p202a Protein Modulates NF-κB Activity by Inhibiting the Binding to DNA of p50/p65 Heterodimers and p65 Homodimers While Enhancing the Binding of p50 Homodimers* , 2003, Journal of Biological Chemistry.

[19]  Taku Sato,et al.  Increased circulating CD11b+CD11c+ dendritic cells (DC) in aged BWF1 mice which can be matured by TNF‐α into BLC/CXCL13‐producing DC , 2002, European journal of immunology.

[20]  P. Lengyel,et al.  The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities , 1996, Molecular and cellular biology.

[21]  P. Lambert,et al.  Material and Methods , 2022 .

[22]  A. Yoshimura,et al.  A novel Zinc finger protein, ZCCHC11, interacts with TIFA and modulates TLR signaling. , 2006, Biochemical and biophysical research communications.

[23]  T. Muta,et al.  Stimulus-specific induction of a novel nuclear factor-kappaB regulator, IkappaB-zeta, via Toll/Interleukin-1 receptor is mediated by mRNA stabilization. , 2005, The Journal of biological chemistry.

[24]  B. Ryffel,et al.  Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice. , 1994, The American journal of pathology.

[25]  T. Hirano,et al.  Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors , 2000, Oncogene.

[26]  M. Yamada,et al.  Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein , 2002, Journal of neurochemistry.

[27]  B. Ryffel,et al.  IFN-γ Receptor Deletion Prevents Autoantibody Production and Glomerulonephritis in Lupus-Prone (NZB × NZW)F1 Mice , 1998, The Journal of Immunology.

[28]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[29]  H. Mcdevitt,et al.  In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon , 1987, The Journal of experimental medicine.

[30]  N. Copeland,et al.  The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation. , 2004, Blood cells, molecules & diseases.

[31]  P. Lengyel,et al.  Increased Expression of Ifi202, an IFN-Activatable Gene, in B6.Nba2 Lupus Susceptible Mice Inhibits p53-Mediated Apoptosis1 , 2006, The Journal of Immunology.

[32]  B. J. Helyer,et al.  Renal Disease associated with Positive Lupus Erythematosus Tests in a Crossbred Strain of Mice , 1963, Nature.

[33]  H. Aburatani,et al.  Induction of Hyper Th1 Cell-Type Immune Responses by Dendritic Cells Lacking the Suppressor of Cytokine Signaling-1 Gene1 , 2005, The Journal of Immunology.

[34]  S. Akira,et al.  Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ , 2004, Nature.

[35]  T. Vyse,et al.  Genetic susceptibility to systemic lupus erythematosus. , 1998, Annual review of immunology.

[36]  P. Lengyel,et al.  p202, an Interferon-inducible Modulator of Transcription, Inhibits Transcriptional Activation by the p53 Tumor Suppressor Protein, and a Segment from the p53-binding Protein 1 That Binds to p202 Overcomes This Inhibition* , 1996, The Journal of Biological Chemistry.

[37]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[38]  T. Asano,et al.  PI3K-mediated negative feedback regulation of IL-12 production in DCs , 2002, Nature Immunology.

[39]  G. Peltz,et al.  Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. , 2001, Immunity.

[40]  P. Lengyel,et al.  The interferon- and differentiation-inducible p202a protein inhibits the transcriptional activity of c-Myc by blocking its association with Max. , 2000, The Journal of biological chemistry.